Related Experiment Video
Updated: Aug 3, 2026
08:57
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Treatment of multiple sclerosis with interferon beta 1b
1Department of Neurology, University of Maryland at Baltimore 21201, USA.
Bailliere'S Clinical Neurology
|April 2, 1999
Summary
Interferon beta 1b effectively treats relapsing remitting and secondary progressive multiple sclerosis, reducing disease activity on MRI scans. However, neutralizing antibodies can limit its efficacy in some patients.
Area of Science:
- Neuroimmunology
- Neurology
- Pharmacology
Background:
- Interferon beta 1b is an established therapy for relapsing remitting multiple sclerosis (RRMS).
- Recent evidence supports its use in slowing disease progression in secondary progressive multiple sclerosis (SPMS).
Purpose of the Study:
- To review the clinical and MRI effects of interferon beta 1b (Betaseron) in multiple sclerosis.
- To discuss its mechanism of action and the impact of neutralizing antibodies.
Main Methods:
- Review of clinical trial data and MRI studies on interferon beta 1b.
- Analysis of patient outcomes and antibody development.
Main Results:
- Interferon beta 1b demonstrates significant reduction in disease activity as evidenced by MRI.
- The drug is generally well-tolerated.
- Neutralizing antibodies can emerge, potentially compromising treatment efficacy.
Conclusions:
- Interferon beta 1b is a valuable therapeutic option for multiple sclerosis, impacting both clinical course and MRI-detected disease activity.
- Monitoring for neutralizing antibodies is crucial for optimizing patient outcomes.
More Related Videos
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...